ImageneBio (IMA) Assets (2020 - 2025)

ImageneBio has disclosed Assets across 6 years of filings, most recently posting $153.0 million for Q4 2025.

• In Q4 2025, Assets rose 860.78% year-over-year to $153.0 million; the TTM figure through Dec 2025 stood at $153.0 million (up 860.78% YoY), while the FY2025 annual figure was $153.0 million, up 860.78% from the prior year.
• Assets came in at $153.0 million for Q4 2025 at ImageneBio, down from $160.9 million in the prior quarter.
• In the past five years, Assets ranged from a high of $293.7 million in Q1 2021 to a low of $15.9 million in Q4 2024.
• Average Assets over 5 years is $184.1 million, with a median of $172.5 million recorded in 2022.
• Year-over-year, Assets tumbled 91.71% in 2024 and surged 860.78% in 2025.
• Over 5 years, Assets stood at $247.9 million in 2021, then plunged by 30.51% to $172.3 million in 2022, then climbed by 11.51% to $192.1 million in 2023, then plunged by 91.71% to $15.9 million in 2024, then surged by 860.78% to $153.0 million in 2025.
• Per Business Quant data, the three most recent Assets figures were $153.0 million in Q4 2025, $160.9 million in Q3 2025, and $126.2 million in Q2 2025.